262 results on '"Kameda, Takuro"'
Search Results
2. Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
3. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
4. The development of adult T cell leukemia/lymphoma in renal transplant recipients: report of two cases with literature review
5. Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
6. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma
7. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma
8. Whole-genome landscape of adult T-cell leukemia/lymphoma
9. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
10. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
11. Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis
12. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma
13. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia
14. Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
15. Supplementary Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
16. Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
17. Clinical characteristics of adult T-cell leukemia/lymphoma infiltration in the gastrointestinal tract
18. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia
19. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan
20. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
21. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
22. Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator
23. Preclinical Translational Research Suggests a Clinical Trial Strategy for a Novel MALT1 Inhibitor ONO-7018/CTX-177 Against Malignant Lymphomas
24. Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers
25. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
26. The effect of CARD11 mutation and HBZ expression accelerated lymphoproliferative diseases and formed the pathological basis for adult T-cell leukemia/lymphoma
27. R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm
28. Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
29. Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation
30. Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan
31. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan
32. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma
33. Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma
34. Preclinical Evaluation of a Novel MALT1 Inhibitor CTX-177 for Relapse/Refractory Lymphomas
35. CARD11 Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ
36. Dissecting Multicellular Ecosystems of HTLV-1 Infection and ATL By Multi-Omics Single Cell Analysis
37. Corrigendum to “Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphomaˮ [Biochem. Biophys. Res. Commun. 485 (1) 2017 144–151]
38. Clinical characteristics of adult T-cell leukemia/lymphoma infiltration in the gastrointestinal tract
39. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
40. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms
41. TP53 and PTEN Mutations Were Shared in Concurrent Germ Cell Tumor and Acute Megakaryoblastic Leukemia
42. Depletion of Neoplastic CD11b Positive Cells in Jak2V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis
43. The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms
44. Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation
45. TET2 Mutation Associated with Organ Infiltrations in ATLL
46. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma.
47. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia
48. Mutant calreticulin causes essential thrombocythemia
49. Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice
50. Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.